XML 56 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders' Equity  
Summary of Restricted Stock Unit Activity

The following table summarizes RSU activity for the years ended December 31 (number of units and aggregate intrinsic value in thousands):

2023

2022

2021

Weighted

Weighted

Weighted

Number

Average

Number

Average

Number

Average

of

Grant-Date

of

Grant-Date

of

Grant-Date

    

Units

    

Fair Value

    

Units

    

Fair Value

    

Units

    

Fair Value

Units outstanding, beginning of year

 

1,565

 

$

145.48

 

1,115

 

$

133.40

 

1,107

 

$

76.10

Granted

 

915

 

227.62

 

1,142

 

143.03

 

686

 

165.67

Released

 

(740)

 

140.81

 

(541)

 

117.49

 

(554)

 

66.23

Forfeited

 

(125)

 

157.95

 

(151)

 

138.99

 

(124)

 

100.64

Units outstanding, end of year

 

1,615

 

193.09

 

1,565

 

145.48

 

1,115

 

133.40

Aggregate intrinsic value at year end

$

417,240

Summary of Performance Stock Unit Activity

The following table summarizes performance stock unit (“PSU”) activity, inclusive of 2019 XSUs, for the years ended December 31 (number of units and aggregate intrinsic value in thousands):

2023

2022

2021

Weighted

Weighted

Weighted

Number

Average

Number

Average

Number

Average

of

Grant-Date

of

Grant-Date

of

Grant-Date

    

Units

    

Fair Value

    

Units

    

Fair Value

    

Units

    

Fair Value

Units outstanding, beginning of year

 

1,369

 

$

43.43

 

1,499

 

$

39.86

 

5,618

 

$

35.71

Granted

 

319

 

218.04

 

158

 

106.57

 

309

 

77.53

Released

 

(1,238)

 

37.98

 

(78)

 

107.58

 

(4,345)

 

37.16

Forfeited

 

(56)

 

48.40

 

(210)

 

41.62

 

(83)

 

40.91

Units outstanding, end of year

 

394

 

201.61

 

1,369

 

43.43

 

1,499

 

39.86

Aggregate intrinsic value at year end

$

101,751

Summary of the Company's Stock Options Activity

The following table summarizes stock option activity for the years ended December 31 (number of options in thousands):

2023

2022

2021

Weighted

Weighted

Weighted

Number

Average

Number

Average

Number

Average

of

Exercise

of

Exercise

of

Exercise

    

Options

    

Price

    

Options

    

Price

    

Options

    

Price

Options outstanding, beginning of year

 

2,438

 

$

28.58

2,438

 

$

28.58

6,366

 

$

28.58

Granted

 

 

 

 

Exercised

 

(1,907)

 

28.58

 

(3,928)

 

28.58

Expired / terminated

 

 

 

 

Options outstanding, end of year

 

531

 

28.58

2,438

 

28.58

2,438

 

28.58

Options exercisable, end of year

531

28.58

1,377

28.58

1,377

28.58

Summary of Stock Options Outstanding and Exercisable

The following table summarizes information about stock options that were fully vested or expected to vest as of December 31, 2023 (number of options in thousands):

Options Outstanding

Options Exercisable

 

 

 

Weighted

 

 

 

Weighted

Weighted

Average

Weighted

Average

 

Number of

 

Average

 

Remaining

 

Number of

 

Average

 

Remaining

Range of

Options

Exercise

Contractual

Options

Exercise

Contractual

Exercise Price

    

Outstanding

    

Price

    

Life (Years)

    

Exercisable

    

Price

    

Life (Years)

$28.58

 

531

$

28.58

 

4.16

 

531

$

28.58

 

4.16

Reported Share-Based Compensation

We account for stock-based compensation using the fair-value method. Reported stock-based compensation expense was classified as follows for the years ended December 31 (in thousands):

    

2023

    

2022

    

2021

Cost of product and service sales

$

6,595

$

4,607

$

5,844

Sales, general and administrative expenses

58,533

51,301

238,813

Research and development expenses

66,230

50,268

58,674

Total stock-based compensation expense

$

131,358

$

106,176

$

303,331

Income tax benefit

$

13,509

 

$

25,154

 

$

30,586